We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
- Authors
Hocking, William G; Hu, Ping; Oken, Martin M; Winslow, Stephen D; Kvale, Paul A; Prorok, Philip C; Ragard, Lawrence R; Commins, John; Lynch, David A; Andriole, Gerald L; Buys, Saundra S; Fouad, Mona N; Fuhrman, Carl R; Isaacs, Claudine; Yokochi, Lance A; Riley, Thomas L; Pinsky, Paul F; Gohagan, John K; Berg, Christine D; PLCO Project Team
- Abstract
The 5-year overall survival rate of lung cancer patients is approximately 15%. Most patients are diagnosed with advanced-stage disease and have shorter survival rates than patients with early-stage disease. Although screening for lung cancer has the potential to increase early diagnosis, it has not been shown to reduce lung cancer mortality rates. In 1993, the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was initiated specifically to determine whether screening would reduce mortality rates from PLCO cancers.
- Publication
Journal of the National Cancer Institute, 2010, Vol 102, Issue 10, p722
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djq126